NB100-56507

antibody from Novus Biologicals

Targeting: NFKBIA IkappaBalpha, IKBA, MAD-3, NFKBI

Western blot (Supportive data in Antibodypedia)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Flow cytometry (Supportive data in Antibodypedia)

Antibody Data

Product number

NB100-56507

Provider

Novus Biologicals

Proper citation

Novus Cat#NB100-56507, RRID:AB_838388

Product name

Mouse Monoclonal IkB-alpha Antibody

Antibody type

Monoclonal

Description

Protein G purified. A 40 kDa band is observed.

Reactivity

Human, Mouse, Rat

Host

Mouse

Isotype

IgG

Vial size

0.1 mg

Concentration

1.0 mg/ml

Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

References

Submitted references

Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation.

Chen Z, Yao L, Liu Y, Pan Z, Peng S, Wan G, Cheng J, Wang J, Cao W
Experimental and therapeutic medicine 2019 Nov;18(5):3741-3750

---

Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis.

Zhu F, Willette-Brown J, Song NY, Lomada D, Song Y, Xue L, Gray Z, Zhao Z, Davis SR, Sun Z, Zhang P, Wu X, Zhan Q, Richie ER, Hu Y
Cell host & microbe 2017 Apr 12;21(4):478-493.e7

---

Ubiquitin-Conjugating Enzyme 9 Phosphorylation as a Novel Mechanism for Potentiation of the Inflammatory Response.

Tomasi ML, Ramani K, Ryoo M
The American journal of pathology 2016 Sep;186(9):2326-36

---

IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB.

Gao Q, Liu Y, Wu Y, Zhao Q, Wang L, Gao S, Wen W, Zhang W, Guo N, Zhou J, Yuan Z
International journal of molecular medicine 2016 Feb;37(2):347-58

---

L-Ascorbyl-2-phosphate attenuates NF-κB signaling in SZ95 sebocytes without affecting IL-6 and IL-8 secretion.

Ikeno H, Apel M, Zouboulis C, Luger TA, Böhm M
Archives of dermatological research 2015 Sep;307(7):595-605

---

The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.

Hochrainer K, Pejanovic N, Olaseun VA, Zhang S, Iadecola C, Anrather J
Nucleic acids research 2015 Nov 16;43(20):9889-904

---

Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury.

Yang XY, Zhao N, Liu YY, Hu BH, Sun K, Chang X, Wei XH, Fan JY, Han JY
Evidence-based complementary and alternative medicine : eCAM 2013;2013:728020

---

Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.

Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, Farb MG, Rosenzweig J, Ruderman N, Vita JA, Hamburg NM
Circulation 2013 Jan 1;127(1):86-95

---

Regulation of nuclear factor κB (NF-κB) transcriptional activity via p65 acetylation by the chaperonin containing TCP1 (CCT).

Pejanovic N, Hochrainer K, Liu T, Aerne BL, Soares MP, Anrather J
PloS one 2012;7(7):e42020

---

TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.

Delhase M, Kim SY, Lee H, Naiki-Ito A, Chen Y, Ahn ER, Murata K, Kim SJ, Lautsch N, Kobayashi KS, Shirai T, Karin M, Nakanishi M
Proceedings of the National Academy of Sciences of the United States of America 2012 Jan 24;109(4):E177-86

---

Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.

Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB
Molecular pharmacology 2010 May;77(5):818-27

---

DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cells.

Nishioka C, Ikezoe T, Jing Y, Umezawa K, Yokoyama A
Immunology 2008 Jun;124(2):198-205

---

An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells.

Yu MC, Su LL, Zou L, Liu Y, Wu N, Kong L, Zhuang ZH, Sun L, Liu HP, Hu JH, Li D, Strominger JL, Zang JW, Pei G, Ge BX
Nature immunology 2008 Aug;9(8):898-907

---

Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.

Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A
Biochemical pharmacology 2007 May 1;73(9):1434-45

---

Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.

Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L, Aifantis I
Nature medicine 2007 Jan;13(1):70-7

---

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.

Endo T, Nishio M, Enzler T, Cottam HB, Fukuda T, James DF, Karin M, Kipps TJ
Blood 2007 Jan 15;109(2):703-10

---

NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins.

Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR
Experimental and molecular pathology 2006 Oct;81(2):123-30

---

Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome.

Strozyk E, Pöppelmann B, Schwarz T, Kulms D
Oncogene 2006 Oct 12;25(47):6239-51

---

Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.

Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H
Toxicology and applied pharmacology 2006 Nov 15;217(1):35-42

---

A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression.

Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C, Sallusto F
The Journal of experimental medicine 2006 Jun 12;203(6):1481-92

---

p120-catenin mediates inflammatory responses in the skin.

Perez-Moreno M, Davis MA, Wong E, Pasolli HA, Reynolds AB, Fuchs E
Cell 2006 Feb 10;124(3):631-44

---

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.

Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M
Cell 2006 Feb 10;124(3):601-13

---

B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.

Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT
Journal of immunology (Baltimore, Md. : 1950) 2005 Sep 1;175(5):2814-24

---

B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.

Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT
Journal of immunology (Baltimore, Md. : 1950) 2005 Sep 1;175(5):2814-24

---

The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells.

Bernasconi D, Amici C, La Frazia S, Ianaro A, Santoro MG
The Journal of biological chemistry 2005 Jun 24;280(25):24127-34

---

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.

Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A
Nature immunology 2005 Aug;6(8):769-76

---

Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50.

Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, Key NS, Geng JG
Journal of immunology (Baltimore, Md. : 1950) 2004 Sep 15;173(6):4207-17

---

Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50.

Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, Key NS, Geng JG
Journal of immunology (Baltimore, Md. : 1950) 2004 Sep 15;173(6):4207-17

---

Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.

Saccani S, Marazzi I, Beg AA, Natoli G
The Journal of experimental medicine 2004 Jul 5;200(1):107-13

---

IkappaB kinase and NF-kappaB signaling in response to pro-inflammatory cytokines.

Delhase M
Methods in molecular biology (Clifton, N.J.) 2003;225:7-17

---

Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke.

Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003 May;23(5):589-98

---

Modulation of NF-kappaB activity by exchange of dimers.

Saccani S, Pantano S, Natoli G
Molecular cell 2003 Jun;11(6):1563-74

---

Modulation of NF-kappaB activity by exchange of dimers.

Saccani S, Pantano S, Natoli G
Molecular cell 2003 Jun;11(6):1563-74

---

NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection.

Goodkin ML, Ting AT, Blaho JA
Journal of virology 2003 Jul;77(13):7261-80

---

NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection.

Goodkin ML, Ting AT, Blaho JA
Journal of virology 2003 Jul;77(13):7261-80

---

PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock.

Ikezoe T, Yang Y, Heber D, Taguchi H, Koeffler HP
Molecular pharmacology 2003 Dec;64(6):1521-9

---

p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment.

Saccani S, Pantano S, Natoli G
Nature immunology 2002 Jan;3(1):69-75

---

Two waves of nuclear factor kappaB recruitment to target promoters.

Saccani S, Pantano S, Natoli G
The Journal of experimental medicine 2001 Jun 18;193(12):1351-9

---

Two waves of nuclear factor kappaB recruitment to target promoters.

Saccani S, Pantano S, Natoli G
The Journal of experimental medicine 2001 Jun 18;193(12):1351-9

Western blot

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Simple Western: IkB-alpha Antibody (6A920) [NB100-56507] - Simple Western lane view shows a specific band for IKB alpha in 0.5 mg/ml of NIH-3T3 lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - Jurkat cells were treated for 30 min with 100 ug/ml ALLN (N-Acetyl-Leu-Leu-Norleucinal; a Calpain inhibitor and also proteasome inhibitor that prevents IkBa dephosphorylation) followed by incubation with (lanes 2 & 4) or without 1 nM TNF-a (1 & 3). The membranes were blotted with NB100-56724 (lanes 1 & 2) or NB100-56507 (that recognizes both non-phospho and phosphorylated forms of IkBa) and immunoreactivity was detected by ECL. The data shows that NB100-56724 detects specifically the phosphorylated form of IkBa.

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - IkBa using NB100-56507 at 2 ug/ml in (A) Daudi and (B) NIH 3T3 whole cell lysate.

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - Lysates of Jurkat human acute T cell leukemia cell line, LNCaP human prostate cancer cell line, PCx2011;3 human prostate cancer cell line, HeLa human cervical epithelial carcinoma cell line, and NIHx2011;3T3 mouse embryonic fibroblast cell line. PVDF membrane was probed with 0.5 ug/mL mouse anti-IkB-a monoclonal (NB100-56507, Novus Biologicals), followed by 1:2000 dilution of the appropriate HRP-conjugated secondary antibody, donkey anti-mouse IgG.

Immunohistochemistry

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Immunohistochemistry-Paraffin: IkB-alpha Antibody (6A920) [NB100-56507] - Human breast probed with IkBa antibody at 5 ug/ml. Human tissue TMA was used for this test. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM sodium citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 min..

Flow cytometry

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Flow Cytometry: IkB-alpha Antibody (6A920) [NB100-56507] - Intracellular staining of 10^6 ThP-1 cells using 0.25 ug of NB100-56507. Shaded histogram represents cells alone, green represents the isotype control, and red represents the IkBa antibody. Novus's intracellular flow kit was used for this test, and an anti-mouse IgG FITC conjugated secondary.

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Flow Cytometry: IkB-alpha Antibody (6A920) [NB100-56507] - An intracellular stain was performed on NIH3T3 cells with IkB-alpha Antibody [6A920] NB100-56507 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550.